Neurofascin‐140 and ‐155 antibodies in an atypical case of poems syndrome
- 24 April 2019
- journal article
- editorial
- Published by Wiley in Muscle & Nerve
- Vol. 60 (1) , E1-E3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathiesNeurology, 2018
- Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathiesJournal of Neuroimmunology, 2017
- POEMSsyndrome: 2017 Update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2017
- Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathyBrain, 2017
- POEMS SYNDROME: AN UPDATEMediterranean Journal of Hematology and Infectious Diseases, 2016
- IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assayJournal of Neuroimmunology, 2016
- Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathyNeurology, 2016
- Characterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathyAnnals of Clinical and Translational Neurology, 2015
- Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIgNeurology, 2014
- Neurofascin as a target for autoantibodies in peripheral neuropathiesNeurology, 2012